These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4401326

  • 1. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ.
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract] [Full Text] [Related]

  • 2. Effects of L-dopa on efflux of cerebral monoamines from synaptosomes.
    Ng KY, Colburn RW, Kopin IJ.
    Nature; 1971 Apr 02; 230(5292):331-2. PubMed ID: 5549411
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of catechol-O-methyl transferase by catechols and polyphenols.
    Baldessarini RJ, Greiner E.
    Biochem Pharmacol; 1973 Jan 15; 22(2):247-56. PubMed ID: 4763253
    [No Abstract] [Full Text] [Related]

  • 4. Metabolism of L-dopa after inhibition of catechol-O-methyl transferase.
    Baldessarini RJ, Chace KV.
    Eur J Pharmacol; 1972 Jan 15; 17(1):163-6. PubMed ID: 5016575
    [No Abstract] [Full Text] [Related]

  • 5. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L.
    Biochem Pharmacol; 1971 Dec 15; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract] [Full Text] [Related]

  • 6. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I, Bartholini G, Tissot R, Fletscher A.
    J Pharm Pharmacol; 1972 Apr 15; 24(4):289-94. PubMed ID: 4402836
    [No Abstract] [Full Text] [Related]

  • 7. [Action of catechol O methyltransferase inhibitors on the distribution of norepinephrine-H 3 in rats].
    Rapin JR, Caillard RC, Cohen Y, Valette G.
    C R Seances Soc Biol Fil; 1971 Apr 15; 165(1):60-4. PubMed ID: 4257753
    [No Abstract] [Full Text] [Related]

  • 8. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M, Rubenson A.
    J Pharm Pharmacol; 1970 Aug 15; 22(8):553-60. PubMed ID: 4394527
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. On the localization of the hypotensive effect of L-dopa.
    Henning M, Rubenson A, Trolin G.
    J Pharm Pharmacol; 1972 Jun 15; 24(6):447-51. PubMed ID: 4403826
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G, Palfreyman MG, Zraïka M, Wagner J, Jung MJ.
    Biochem Pharmacol; 1980 Sep 15; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract] [Full Text] [Related]

  • 15. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL, Calne DB, George CF, Vakil SD.
    Clin Sci; 1972 Dec 15; 43(6):851-9. PubMed ID: 4646277
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S.
    Neuropharmacology; 1974 Aug 15; 13(8):729-39. PubMed ID: 4444759
    [No Abstract] [Full Text] [Related]

  • 18. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M.
    Acta Pharmacol Toxicol (Copenh); 1969 Aug 15; 27(2):135-48. PubMed ID: 5819569
    [No Abstract] [Full Text] [Related]

  • 19. Block of cerebral actions of L-dopa with methyl receptor substances.
    Cotzias GC, Tang L, Ginos JZ, Nicholson AR, Papavasiliou PS.
    Nature; 1971 Jun 25; 231(5304):533-5. PubMed ID: 4934569
    [No Abstract] [Full Text] [Related]

  • 20. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G, Blum JE, Pletscher A.
    J Pharm Pharmacol; 1969 May 25; 21(5):297-301. PubMed ID: 4390121
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.